Big Data Investments in Healthcare and Pharmaceutical Industry to grow approx. 12% in next 3 years

Big Data investments in the Healthcare and Pharmaceutical Industry will account for nearly $4.7 Billion in 2018 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of approximately 12% over the next three years.

Big Data in the Healthcare & Pharmaceutical Industry: 2018 - 2030 - Opportunities, Challenges, Strategies & Forecasts report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2018 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 37 use cases, 6 regions and 35 countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

VIEW DETAILED TOC, LIST OF TABLES & FIGURES AND COMPLETE LIST OF ALL COMPANIES MENTIONED IN THIS REPORT.
https://www.researchbymarkets.com/report/big-data-in-the-healthcare-pharmaceutical-industry-2018-2030-opportunities-challenges-strategies-forecasts-30024.html

Key Questions Answered:
The report provides answers to the following key questions:

How big is the Big Data opportunity in the healthcare and pharmaceutical industry?
How is the market evolving by segment and region?
What will the market size be in 2021, and at what rate will it grow?
What trends, challenges and barriers are influencing its growth?
Who are the key Big Data software, hardware and services vendors, and what are their strategies?
How much are healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders investing in Big Data?
What opportunities exist for Big Data analytics in the healthcare and pharmaceutical industry?
Which countries, application areas and use cases will see the highest percentage of Big Data investments in the healthcare and pharmaceutical industry?

REQUEST FOR READY AND IMMEDIATELY AVAILABLE SAMPLE PAGES OF THIS REPORT:
https://www.researchbymarkets.com/sample-request/30024

Key Findings:
The report has the following key findings:

In 2018, Big Data vendors will pocket nearly $4.7 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry. These investments are further expected to grow at a CAGR of approximately 12% over the next three years, eventually accounting for more than $7 Billion by the end of 2021.

Big Data and advanced analytics are driving a paradigm shift in the healthcare and pharmaceutical industry with multiple innovations ranging from precision medicine and digital therapeutics to the adoption of accountable and value-based care models.
Drug developers are making substantial investments in Big Data and artificial intelligence-driven drug discovery platforms to shorten the process of successfully discovering promising compounds. In addition, Big Data technologies are increasingly being utilized to streamline clinical trials, enabling biopharmaceutical companies to significantly lower costs and accelerate productive trials.

The growing adoption of Big Data technologies has also brought about an array of benefits for hospitals and other healthcare facilities. Based on feedback from healthcare providers worldwide, these include but are not limited to cost savings in the range of 20-30%, an increase in patient access to services by more than 35%, growth in revenue by up to 30%, a reduction in emergency room visits by 10%, a drop in patient wait times by 30-60%, improvements in outcomes by as much as 20%, a 10-50% decline in mortality rates for conditions such as heart failure, and a reduction in the occurrence of hospital acquired and surgical site infections by nearly 60%.

Topics Covered:
The report covers the following topics:

Big Data ecosystem
Market drivers and barriers
Enabling technologies, standardization and regulatory initiatives
Big Data analytics and implementation models
Business case, application areas and use cases in the healthcare and pharmaceutical industry
Over 40 case studies of Big Data investments by healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders
Future roadmap and value chain
Profiles and strategies of over 270 leading and emerging Big Data ecosystem players
Strategic recommendations for Big Data vendors, and healthcare and pharmaceutical industry stakeholders
Market analysis and forecasts from 2018 till 2030

ASK SPECIFIC QUERIES REGARDING THIS REPORT:
https://www.researchbymarkets.com/inquiry/30024

Contact Us:
Research By Markets
Ritesh Tiwari | Sales
Email: enquiry@researchbymarkets.com

About Us:

"Research By Markets" is a Market Research Reports Depository. Our Latest Market Research Reports cover a lot of Industry Sectors - Aerospace and Defense, Automotive and Transportation, Chemicals and Materials, Consumer Goods and Services, Energy and Power, Environmental, Food and Beverages, Healthcare, Information Technology, Manufacturing and Construction, Medical Devices, Petroleum, Pharmaceuticals, Semiconductor and Electronics, Telecommunications and more.

We are trusted by Fortune 500 companies for our client centric support. We have helped our clients in procuring research studies as per their requirements and also ensured they get proper post purchase support. We ensure that all our client queries are addressed in quick time.

Our website and payment gateway are completely secured to prevent any client information data leak. We do not store any credit card information in our database or emails. We conform to strict security standards and our Technology team works hard to keep our servers secure and protected at all times.

Our Sales Team does not bother clients with phone calls unless requested by the client itself. Nor do we run any email marketing campaigns or bombard clients with repeated follow up emails.

Corporate Clients can also avail discounts. To know more get in touch with us.

We strive our best to ensure that our clients have a seamless experience and are happy and smiling every time they do business with us.

"A satisfied customer is a the best business strategy of all" - Michael LeBoeuf, Business Author.

https://www.researchbymarkets.com/aboutus

Research By Markets
E/3, Ganga Homes,
Behind Bank Of India,
Viman Nagar,
Pune 411 014.
Maharashtra, India

This release was published on openPR.